share_log

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More

Benzinga ·  10/07/2023 05:07

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares NY Mets owner Steve Cohen has bought as many as 119,092,680 ordinary shares of clinical-stage biopharmaceutical company Bionomics Limited (NASDAQ:BNOX) through his Point72 asset management firm, again showing support for the biopharma sector (See recent buy of Cybin (NYSE: CYBN) shares.) The Australia-based company currently trades on the Nasdaq and in the Frankfurt Stock Exchange (Fra) by means of American Depositary Shares (ADS) and recently announced its delisting intentions from the Australian Securities Exchange (ASX) following a U.S.-focused transformation plan. Read more HERE. Gov Newsom Green

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment